Med-Tech Innovation Advanced Wound Care
Table I: Professional wound care market forecast, 2010–2015 (US$ million)
Advanced Moist
Biologics NPWT Other Total Advanced Traditional Dry* Total Wound Care
2010E 3,290 380
1,555 115
5,340 3,170 8,510
2011E 3,430 410
1,595 125
5,560 3,195 8,755
2012E 3,600 445
1,690 135
5,870 3,225 9,095
2013E 3,785 500
1,800 145
6,230 3,300 9,530
2014E 3,980 590
1,900 155
6,625 3,315 9,940
2015E 4,200 710
2,000 165
7,075 3,320 10,395
Source: Espicom internal estimates *Estimates are based on dry traditional product sales in the professional healthcare market only
Table II: Global wound care market growth by product, 2008–2015E (%)
Advanced Moist
Biologics NPWT Other Total Advanced Traditional Dry* Total Wound Care
2008 5.9 11.4 8.5 20.0 7.3 -1.4 3.7
2009 4.8 10.2 2.4 9.4 4.5 0.5 2.9
2010E 4.6 10.1 1.0 9.5 4.0 0.6 2.7
2011E 4.3 7.9 2.6 8.7 4.1 0.8 2.9
2012E 5.0 8.5 6.0 8.0 5.6 0.9 3.9
2013E 5.1 12.4 6.5 7.4 6.1 2.3 4.8
2014E 5.2 18 5.6 6.9 6.3 0.5 4.3
2015E 5.5 20.3 5.3 6.5 6.8 0.2 4.6
Source: Espicom internal estimates *Estimates are based on dry traditional product sales in the professional healthcare market only
Opportunities
Each sector of the advanced wound care has its own opportunities and challenges and these are discussed in detail in the Espicom report. MOIST WOUND DRESSINGS. In brief, this sector of the market is
a relatively mature area and many of the market-leading products have been offered for some years, leading to strong brand recognition and user- friendliness. Espicom believes this sector will be negatively affected by weaker pricing and the increased adoption of alternative new technologies. However, some growth will come from the growing use of antimicrobial dressings and the development of new composite products that offer advancements over earlier products. New products and the increasing interest in technologies that do not lead to antibiotic resistance are expected to lead to market growth in this area. However, there remains little clinical evidence to show the effectiveness of these technologies. Currently, the most commonly used antimicrobial dressings contain silver, but recent studies of silver-containing products have failed to find a benefit
Montreal welcomes the world
Where science and business connect is the theme of the 16th International Meeting on Radiation Processing (IMRP) being held in Montreal on 13–16 June 2011. It will examine advancements in gamma ray, electron beam and X-ray technology.
The event begins with a day of optional, in-depth workshops: Dosimetry by ASTM E10.01; Radiation Sterilisation and the Practical Application of ISO 11137 for medical devices by the Panel on Gamma and Electron irradiation; and Latest Developments with Combination Drug-Device Healthcare Products by iiA.
36 ¦ April 2011
The three day conference programme addresses evolving applications and material
enhancements.The keynote speaker is Dr Richard Raposa, Divisional Vice President, BVS Abbott Vascular, who will assess collaboration between industry and science and offer a futuristic perspective.
Other speakers include Dr John Kowalski, Sterigentics International, speaking on Method VDmax – Expanded Doses; and Arthur Dumba, Isotron UK, who will outline Modification of Biodegradable Polymers Using Ionising Irradiation.
www.imrp2011.com
www.med-techinnovation.com
for them compared with products that do not contain silver. So far, demand for silver-containing products has continued to grow. This is despite the negative media attention resulting from the publication of these studies, which indicates the strong market need for antimicrobial dressings. However, growth has slowed somewhat and the products are increasingly being used for infected wounds, rather than to prevent infection from occurring. Given the high price of silver-containing products, well- designed studies that provide evidence that the products are effective are required for the market to continue to grow. There is also scope for other antimicrobial technologies to take the place of silver products should they be shown to be more clinically effective. NEGATIVE PRESSURE WOUND THERAPY. In this sector, given the fact that KCI has more than 90% market share, the company’s successes and failures drive market growth or declines. Growth is currently being driven by the rising adoption of the technology as awareness increases and more clinical evidence as to its benefits is published. In addition, new applications such as in surgery are expanding the market for NPWT. With approximately 70% of the current market being in the US, there is wide scope to increase adoption in other regions of world.
BIOLOGICS PRODUCTS. This sector is characterised
by more innovation than any other sector of the advanced wound care market, although this is the smallest sector and barriers to market entry are the highest. Although Espicom predicts solid market growth for biologic products to 2015, this will be dependant on companies having the funds to bring products to market and successfully completing their clinical development programmes. These products can also often mean a change of practice for users and a higher cost than older products, which may affect adoption rates and therefore the development of this market. Espicom’s report, “The Global Advanced Wound Care Market to 2015,” includes competitive evaluations of major and emerging companies, regional perspectives and insights into opportunity areas.
Espicom Business Intelligence, Lincoln House, City Fields Business Park, City Fields Way, Chichester PO20 2FS,UK, tel. +44 (0)1243 533 322,
www.espicom.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54